✓ Last verified: January 20, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff

Known For: Pacific Ketamine Group in Torrance is led by Dr. Kartik Ananth, one of only 55 physicians in the US to hold double board certification in both Pain Management and Neuropsychiatry. Founded in 2019, the practice specializes in IV ketamine infusion therapy for treatment-resistant depression, PTSD, severe anxiety, and chronic pain conditions. Their unique dual expertise bridges the gap between mental health and pain management.
| Review Scores | ⭐ Highly rated for empathetic care |
| Location | Torrance, California |
| Address | 23150 Crenshaw Blvd, Suite 110, Torrance, CA 90505 |
| Phone | (310) 928-6863 |
| Website | pacificketaminegroup.com |
| Treatments | IV Ketamine Infusion Therapy |
| Conditions Treated | Treatment-Resistant Depression, PTSD, Severe Anxiety, Chronic Pain, Neuropathic Pain |
| Cost | Contact clinic for current pricing |
| Insurance | Contact clinic for insurance details |
| KAP Available? | Contact clinic for psychotherapy integration options |
| Clinical Lead | Dr. Kartik Ananth, MD (Double Board-Certified: Pain Management & Neuropsychiatry) |
💡 No clinic-specific pricing posted? See our ketamine therapy cost guide for typical pricing ranges by treatment type and insurance pathways.
HealingMaps Take: Pacific Ketamine Group benefits from Dr. Ananth’s rare dual board certification in both pain management and neuropsychiatry — a combination that gives him unusually deep insight into how ketamine can address both the mental health and pain dimensions of a patient’s condition. Reviews consistently praise the empathetic care and serene clinic atmosphere. While parking during peak hours has been noted as a challenge, the clinical expertise and holistic treatment approach make this a top-tier option in the South Bay.
Market Position: Pacific Ketamine Group treats both depression and PTSD — the two most common ketamine therapy indications, accounting for 34% of HealingMaps patient inquiries.
Industry pricing reference. Pacific Ketamine Group has not published specific per-session pricing — contact the clinic directly for a quote. The calculator above shows typical metro-level cost estimates across protocols, not this clinic’s specific prices.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine Infusion | $350–$650/session | ✓ |
| Spravato (esketamine) | $0–$250 copay (insured) | — |
| IM Ketamine | $250–$400/injection | — |
| KAP (with integrated talk therapy) | $400–$1,200/session | — |
| At-home oral troches | $150–$300/month | — |
This 4-question summary is matched to the protocols and conditions Pacific Ketamine Group treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
Pacific Ketamine Group treats depression via IV ketamine (off-label, evidence-based). Insurance coverage is rare for IV/KAP — most patients pay out of pocket. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
Yes — Pacific Ketamine Group treats chronic pain. They use IV ketamine for pain, which typically means longer infusion times and higher cumulative doses than mental-health protocols. Common indications include complex regional pain syndrome (CRPS), fibromyalgia, and certain neuropathic pain syndromes. Pain pricing varies significantly by structure: per-infusion vs. multi-day inpatient packages — verify how this clinic structures their billing.
Yes — Pacific Ketamine Group treats PTSD. Ketamine for trauma differs from depression treatment: dosing is often lower per session, and pairing the protocol with trauma-focused therapy between sessions is common. A reasonable consult question: whether PTSD patients here typically use ketamine alone or alongside an outside therapist.
Yes — Pacific Ketamine Group treats anxiety, including generalized anxiety, social anxiety, and panic disorder. The evidence base for ketamine in anxiety is less robust than for depression, but it can be a meaningful option for patients who haven’t responded to SSRIs or benzodiazepines. Worth asking which of their protocols they typically recommend for anxiety-primary patients.
Leave a Reply